[Conformal radiotherapy in cancer of the upper aerodigestive tract].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 10572511)

Published in Cancer Radiother on December 02, 1999

Authors

P Pommier1, M Lapeyre, C Ginestet, I Buchheit, M P Sunyach, O Chapet, X Montbarbon, C Marchal, P Aletti, C Carrie, P Bey

Author Affiliations

1: Service de radiothérapie, Centre Léon-Bérard, Lyon, France.

Articles by these authors

SOR: project methodology. Br J Cancer (2001) 5.24

DNA transformation leads to pilin antigenic variation in Neisseria gonorrhoeae. Nature (1988) 2.98

Anti-proliferative properties of DL-alpha-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylase. Biochem Biophys Res Commun (1978) 2.74

DL-alpha-(Difluoromethyl)arginine: a potent enzyme-activated irreversible inhibitor of bacterial decarboxylases. Biochemistry (1981) 2.30

Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol (1997) 2.20

Pilin expression in Neisseria gonorrhoeae is under both positive and negative transcriptional control. EMBO J (1988) 1.88

Trypanosoma brucei TBRGG1, a mitochondrial oligo(U)-binding protein that co-localizes with an in vitro RNA editing activity. J Biol Chem (1998) 1.87

DNA sequence encoding the NH2-terminal peptide involved in transport of lambda receptor, an Escherichia coli secretory protein. Proc Natl Acad Sci U S A (1980) 1.87

Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Fédération Nationale des Centres de Lutte Contre le Cancer. Radiology (2000) 1.84

Alpha-methyl ornithine, a potent competitive inhibitor of ornithine decarboxylase, blocks proliferation of rat hepatoma cells in culture. Proc Natl Acad Sci U S A (1976) 1.76

malB region in Escherichia coli K-12: specialized transducing bacteriophages and first restriction map. J Bacteriol (1978) 1.74

Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol (2005) 1.70

Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys (1998) 1.70

Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer (1997) 1.67

[An exceptional variety of medulloblastoma: melanotic medulloblastoma]. Ann Pathol (1997) 1.65

Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest (1997) 1.65

Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas. Int J Radiat Oncol Biol Phys (1997) 1.60

Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer (1997) 1.53

Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. J Biol Chem (1992) 1.52

Synthesis and maturation of lambda receptor in Escherichia coli K-12: in vivo and in vitro expression of gene lamB under lac promoter control. Proc Natl Acad Sci U S A (1980) 1.49

The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression. Blood (1995) 1.48

Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer (1995) 1.48

Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol (2004) 1.47

[Neck dissection following chemoradiation for node positive head and neck carcinomas]. Cancer Radiother (2009) 1.46

Influence of tumoral, radiobiological, and general factors on local control and survival of a series of 361 tumors of the velotonsillar area treated by exclusive irradiation (external beam irradiation+brachytherapy or brachytherapy alone) Int J Radiat Oncol Biol Phys (1994) 1.44

[Treatment of lung cancer in the elderly]. Rev Mal Respir (2004) 1.39

[Treatment of bronchial carcinoma in the elderly]. Rev Mal Respir (2002) 1.37

N-2,3-Butadienyl-1,4-butanediamine derivatives: potent irreversible inactivators of mammalian polyamine oxidase. J Med Chem (1985) 1.36

Genetic study of a membrane protein: DNA sequence alterations due to 17 lamB point mutations affecting adsorption of phage lambda. EMBO J (1983) 1.34

A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol (1993) 1.30

Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys (1997) 1.30

Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens (1998) 1.29

Spheroids in radiobiology and photodynamic therapy. Crit Rev Oncol Hematol (2001) 1.29

Control of pilus expression in Neisseria gonorrhoeae as an original system in the family of two-component regulators. Mol Microbiol (1991) 1.24

Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer (2001) 1.18

Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpain. Biochem Biophys Res Commun (1988) 1.18

What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer (2012) 1.17

Salvage irradiation by brachytherapy of velotonsillar squamous cell carcinoma in a previously irradiated field: results in 73 cases. Int J Radiat Oncol Biol Phys (1994) 1.15

Occurrence of polyglucosan bodies in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1992) 1.12

Specific inhibition of polyamine oxidase in vivo is a method for the elucidation of its physiological role. Biochim Biophys Acta (1985) 1.11

Evaluation of the Nuclisens HIV-1 QT assay for quantitation of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol (1998) 1.11

alpha-difluoromethyl DOPA, a new enzyme-activated irreversible inhibitor of aromatic L-amino acid decarboxylase. J Neurochem (1978) 1.09

Neisseria gonorrhoeae prepilin export studied in Escherichia coli. J Bacteriol (1991) 1.09

Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg (2003) 1.09

Antimalarial polyamine analogues. J Med Chem (1991) 1.06

Spinal cord compression by secondary epi- and intradural metastases in childhood. Childs Nerv Syst (1997) 1.06

Use of the infra hyoid musculo-cutaneous flap in soft palate reconstruction. Eur J Surg Oncol (2006) 1.05

Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer (2001) 1.04

Stroke risk in patients with carotid stenosis. Lancet (1987) 1.04

Bacteriophage lambda-E. coli K12 vector-host system for gene cloning and expression under lactose promoter control: I. DNA fragment insertion at the lacZ EcoRI restriction site. Mol Gen Genet (1979) 1.02

DL-a-Monofluoromethylputrescine is a potent irreversible inhibitor of Escherichia coli ornithine decarboxylase. Biochem J (1982) 1.02

Inhibition of human neutrophil elastase with peptidyl electrophilic ketones. 2. Orally active PG-Val-Pro-Val pentafluoroethyl ketones. J Med Chem (1994) 1.01

[Methodology of the development of diagnostic and therapeutic standards, options and recommendations in oncology]. Bull Cancer (1995) 1.01

Detection of errors in individual patients in radiotherapy by systematic in vivo dosimetry. Radiother Oncol (1995) 1.00

MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1989) 0.99

Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol (2001) 0.99

PulO, a component of the pullulanase secretion pathway of Klebsiella oxytoca, correctly and efficiently processes gonococcal type IV prepilin in Escherichia coli. Mol Microbiol (1992) 0.98

[Enzymatic activities of the mitochondrial respiratory chain in child cardiomyopathies. 34 cases prospectively studied by endomyocardial biopsy]. Arch Mal Coeur Vaiss (1992) 0.98

Genetics strongly determines the wall thickness of the left and right carotid arteries. Hum Genet (1998) 0.98

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998). Ann Oncol (2013) 0.98

[Oxygen therapy in hyaline membrane disease. Respiration in constant depression]. J Gynecol Obstet Biol Reprod (Paris) (1972) 0.97

Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on polyamine levels in rat tissues. Life Sci (1979) 0.97

Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Fédération Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol (1995) 0.96

Esophageal cancer: determination of internal target volume for conformal radiotherapy. Radiother Oncol (2006) 0.96

Bilateral periventricular nodular heterotopia in France: frequency of mutations in FLNA, phenotypic heterogeneity and spectrum of mutations. J Neurol Neurosurg Psychiatry (2009) 0.96

Catalytic irreversible inhibition of bacterial and plant arginine decarboxylase activities by novel substrate and product analogues. Biochem J (1987) 0.96

[Neonatal thrombosis of the aortic arch]. Pediatrie (1993) 0.96

Conservation of Neisseria gonorrhoeae pilus expression regulatory genes pilA and pilB in the genus Neisseria. Infect Immun (1990) 0.95

[Standards, Options, and Recommendations: a space in Bulletin du Cancer to facilitate their dissemination]. Bull Cancer (1998) 0.95

[Radiation oncology training in France: demography, analysis of motivations of the young specialists, evaluation of the training]. Cancer Radiother (2005) 0.95

Desmoplastic small round cell tumors of the abdomen. Cancer (1994) 0.94

Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: preliminary results. Int J Radiat Oncol Biol Phys (2000) 0.94

Alpha-diketone and alpha-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases. J Med Chem (1990) 0.93

Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G. J Med Chem (1990) 0.93

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. Eur J Cancer (2009) 0.93

Breast carcinoma located in ectopic breast tissue: a case report and review of the literature. Oncol Rep (1998) 0.92

Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer. Cancer Radiother (2009) 0.91

Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques. Radiother Oncol (1992) 0.91

Symptomatic Radionecrosis after AVM Stereotactic Radiosurgery. Study of 16 Consecutive Patients. Interv Neuroradiol (2005) 0.91

Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiother Oncol (2009) 0.90

[Marfan's disease in a newborn infant with polyvisceral lesions. Anatomo-clinic study]. Ann Pediatr (Paris) (1968) 0.90

French version of FACT-G: validation and comparison with other cancer-specific instruments. Eur J Cancer (2004) 0.89

[Partial and transitory erythrocyte galactokinase deficiency in a newborn. Biochemical study]. Arch Fr Pediatr (1970) 0.89

The study of tumoral, radiobiological, and general health factors that influence results and complications in a series of 448 oral tongue carcinomas treated exclusively by irradiation. Int J Radiat Oncol Biol Phys (1994) 0.89

A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors. J Med Chem (1990) 0.89

Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity. Br J Cancer (1998) 0.89

Inhibition of monoamine synthesis by irreversible blockade of aromatic aminoacid decarboxylase with alpha-monofluoromethyldopa. Life Sci (1979) 0.88

Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical results. Urology (2008) 0.88